Synthesis and biological activity of 1,2,3,4-tetrahydroquinoline and 3,4-(1H)-dihydroquinolin-2-one analogs of retinoic acid

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 18, 1997, Pages 2373-2378

  Beard, Richard L ^a   Teng, Min ^a   Colon, Diana F ^a   Duong, Tien T ^a   Thacher, Scott M ^a   Arefieg, Taghreed ^a   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4 TETRAHYDROQUINOLINE DERIVATIVE; AROTINOID; ORNITHINE DECARBOXYLASE; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; LIPOPHILICITY; MOUSE; NONHUMAN; SKIN; STRUCTURE ACTIVITY RELATION;

EID: 0030749053     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00435-6     Document Type: Article

References (31)

1. nd ed.; Sporn, M. B.; Roberts, A. B.; Goodman, D. S., Eds.; Raven: New York, 1994.
2. (a) Petkiovich, M.; Brand, N. J.; Krust, A.; Chambon, P. Nature 1987, 330, 444.
3. (b) Giguere, V.; Ong, E. S.; Segui, P.; Evans, R. M. Nature 1987, 330, 624.
4. (c) Brand, N.; Petkovich, M. Krust, A.; Chambon, M.; de The, H.; Marchio, A.; Dejean, A. Nature 1988, 332, 850.
5. (d) Krust, A. Kastner, P.; Petkovich, M.; Zelent, A.; Chambon, P. Proc, Natl. Acad. U.S.A. 1989, 86, 5310.
6. (a) Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A., Stein, R.B.; Eichele, G.; Evans, R. M.; Thaller, C. Cell 1992, 68, 397.
7. (b) Levin, A. A.; Sturzenbecker, L. J.; Kazmer, S.; Bosakowski, T; Huselton, C.; Allenby, G.; Speck, J.; Kratzeisen, CI.; Rosenberger, M.; Lovey, A.; Grippo, J. F. Nature 1992, 355, 359.
8. Yang-Yen, H.-F.; Zhang, X.-K.; Graupner, G.; Tzukerman, , M.; Sakamoto, B.; Karin, M.; Phahl, M. New Biologist 1991, 3, 1206.
9. (a) Ref 1, pp 573-630;
10. (b) Tallman, M. S.; Wiernik, P. H. J. Clin. Pharmacol. 1992, 32, 868.
11. (a) Ref 1, pp. 373-390.
12. (b) Hope, W. C.; Patel, B. J.; Fiedler-Nagy, C.; Wittreich, B. H. Inflamation 1990, 14, 543.
13. (c) Hanglow, A. C.; Bachmann, H.; Rosenberger, M.; Coffey, J. F. Int. J. Immunopharmac. 1990, 12, 703.
14. (d) Sidell, N.; Chang, B.; Bhatti, L. Cellular Immunology 1993, 146, 28.
15. Verstraeten, T.; Hartzer, M.; Wilcox, D. K.; Cheng, M. Invest. Ophthalmol. Vis. Sci. 1992, 33, 2830.
16. (a) Ref 1, pp 631-638.
17. (b) Retinoids: Present and Future. Proceedings of a Sympisium Held at the 18th World Congress of Dermatology. Shalita, A. R.; Fritsch, P. O., Eds.; Supplement to J. Am. Acad. Dermatol. 1992, 27 (6), part 2.
18. Review: Vahlquist, A. In Retinoids: Present and Future. Proceedings of a Sympisium Held at the 18th World Congress of Dermatology. Shalita, A. R.; Fritsch, P. O., Eds.; Supplement to J. Am. Acad. Dermatol. 1992, 27 (6), pp S29 - 233.
19. Agnish, N. D.; Kochhar, D. M. In Retinoids and Clinical Practice; Korean, G., Ed.; Mercel Dekker: New York 1992; pp 47-76.
20. (a) Teng, M.; Duong, T. T., Klein, E. S.; Pino, M. E.; Chandraratna, R. A. S. J. Med. Chem. 1996, 39, 3035.
21. (b) Johnson, A. T.; Klein, E. S.; Wang, L. Pino, M. E.; Chandraratna, R. A. S. J.Med. Chem. 1996, 39, 5027, and references therein.
22. 13C NMR, IR, and HRMS data consistent with their structures.
23. Frickel, F.-F.; Nurrenbach, A. U.S Patent 4,578,498, Mar. 25, 1986.
24. The starting aryl bromides 20 and 24 were prepared according to the literature procedure: Teng, M.; Beard, R. L.; Duong, T. T.; Colon, D. F.; Chandraratna, R. A. U.S. Patent 5,616,712, April 1, 1997.
25. (a) Giguere, V.; Ong, E. S.; Segui, P.; Evans, R. M. Nature 1987, 330, 624.
26. (b) Allegretto, E. A.; McClurg, M. R.; Lazarchik, S. B.; Clemm, D. L.; Kerner, S. A.; Elgrot. M. G.; Boehm, M. F.; White, S. K.; Pike, J. W.; Heyman, R. A. J. Biol. Chem. 1993, 268, 26625.
27. Chandraratna, R. A. S.; Henry, E.; Attard, J.; Gillett, S. J.; Song, T.; Garst, M. E.; Nagpal, S.; Athanikar, Arefieg, T.; Gil, D. W.; Wheeler, L. A.; Lew-Kaya, D.; Sefton, J. In Proceedings of the XIIIth International Symposium on Medicinal Chemistry. Muller, J.-C., Ed., Supplement to Eur. J. Med. Chem. 1995, 30, 505s.
28. 50 determination of a single experiment with triplicate determinations. Standard errors for this assay system are, on average, approximately 15% of the mean values.
29. Verma, A. K.; Rice, H. M.; Shapas, B. G.; Boutwell, R. K. Analogs.Cancer Research 1978, 38, 793.
30. 60 values of 0.33 nM, 5.0 nM, and < 0.1 nM, respectively.
31. Elder, J. T.; Fisher, G. J.; Zhang, Q.-Y.; Eisen, D.; Krust, A.; Kastner, P.; Chambon, P.; Voorhees, J. J. J. Invest. Dermatol. 1991, 96, 425.